Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy.
about
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathyOne-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis.Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.Diagnosis and interventions for central serous chorioretinopathy: review and update.Central serous chorioretinopathy: update on pathophysiology and treatment.Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series.System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy.Photodynamic therapy: current role in the treatment of chorioretinal conditionsSelective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study.Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy.Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy.Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy.Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathyPhotodynamic therapy for central serous chorioretinopathy.Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy.Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report.Photodynamic therapy and central serous chorioretinopathy.Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.Long term outcomes for patients treated with half-fluence photodynamic therapy for chronic central serous chorioretinopathy: a case series.Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis.Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.Efficacy of oral rifampicin in chronic central serous chorioretinopathyChoroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy
P2860
Q26824756-6DF1208E-694B-433E-93DE-23F0034DC2FEQ31112014-BB99DC65-E56B-4616-9053-C85E36C42BF3Q33705962-B4694DD4-5E7D-431A-A22B-509895DC3C3BQ34334335-E931B9FC-97E8-48CC-8B21-9340057764AAQ34587658-84EDB026-8FB7-4669-BB6F-F88D41957AD7Q35176611-02751170-26CE-4CB3-8338-625019FF57D9Q35209632-A5EC17B9-991D-4063-BA98-21198C739269Q35888341-9CC71F43-BAFE-408F-8E60-85233735B623Q35906128-900AD3B2-3CCF-4CE7-AB27-DD1B1877FBD7Q36123646-01617421-AD29-446C-BC98-73AC05C2501AQ36304949-321808DF-ED2B-41D3-8D25-5F55AFC625BDQ36326807-FE278881-BEE3-4004-A150-F4C5E5D13FE2Q36407625-8F344F8E-7495-458F-B004-312BE8B88306Q37478532-6E5FA971-2B84-4AE4-AC29-DB0B416C375FQ38221648-B23421D7-B88A-4089-B89B-B476BF5B0AA4Q38330486-BBF29218-7288-44F4-8A4C-5278F4457E84Q38701151-E21AC6C9-FE9C-43ED-9834-C2AB296227DEQ41785680-B3E33211-DD75-468B-A0DC-E4173A46E53EQ41990230-FB1226B3-159A-4BB5-8E9F-DD32EF3A4BC7Q50224467-2A90AAFF-1641-4983-BB72-B1AB7A544EF5Q50484261-322098BF-06AC-4A07-A78F-709BB5A3159AQ51746723-5119BC19-95A5-4C63-96A1-B0D26AB037ACQ54571267-31DAC807-30F8-49BB-BF96-57DC2E32ED0BQ54987173-D8B6FDB4-A611-46C3-A17E-E71BB38FA39FQ57814622-93EE4413-AE39-4537-8F15-33A5D4ABE1ECQ58701633-CE281DD6-811A-49D8-B5CE-3694F35CEC8A
P2860
Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of efficacy and saf ...... tral serous chorioretinopathy.
@en
Comparison of efficacy and saf ...... tral serous chorioretinopathy.
@nl
type
label
Comparison of efficacy and saf ...... tral serous chorioretinopathy.
@en
Comparison of efficacy and saf ...... tral serous chorioretinopathy.
@nl
prefLabel
Comparison of efficacy and saf ...... tral serous chorioretinopathy.
@en
Comparison of efficacy and saf ...... tral serous chorioretinopathy.
@nl
P2093
P1433
P1476
Comparison of efficacy and saf ...... tral serous chorioretinopathy.
@en
P2093
Hyeong Gon Yu
Joo Young Shin
Kyu Hyung Park
Se Joon Woo
P304
P356
10.1097/IAE.0B013E3181E378F2
P577
2011-01-01T00:00:00Z